Trial Profile
Inflammation and Coronary Endothelial Function in Patients With Coronary Artery Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Oct 2021
Price :
$35
*
At a glance
- Drugs Colchicine (Primary) ; Methotrexate (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 11 Sep 2020 Status changed from active, no longer recruiting to completed.
- 10 Sep 2019 Planned End Date changed from 1 Feb 2020 to 1 Feb 2021.
- 10 Sep 2019 Planned primary completion date changed from 1 Aug 2019 to 1 Aug 2020.